对于化工企业而言，破除"内卷"绝非一朝一夕之功，而是一场深刻的自我革命。它要求企业决策者具备 战略耐性，坚持长期主义，建立系统思维，将战略、运营、生态视为一个整体进行协同推进，同时还要 保持开放心态，敢于合作，善于在产业链中重新定位自己的价值。 单打独斗无法破除行业性"内卷"。化工企业必须主动构建或融入健康的产业生态，重塑产业价值链， 从"内部管控"转向"生态协同"，从"零和博弈"转向"和谐共生"，在合作中创造增量价值，这样方能跳 出"内卷"红海，驶向高质量增长的蓝海。 三是搭建开放式创新平台。与重点高校、科研院所等建立创新联合体，共同攻关行业共性技术难题；通 过设立产业基金、举办创新挑战赛等方式，吸引外部创新资源。这样可以分散研发风险，加速技术突 破，避免在低水平技术上重复投入，共同把行业的"蛋糕"做大。 四是引领或参与制定行业标准。行业领军企业、产业链主企业要牵头或主导制定新的产品标准、绿色标 准、数字化接口标准等。链上合作企业也要积极参与，将产业安全、增值服务、客户诉求融入新标准。 这不仅能规范市场竞争，淘汰落后产能，更能让先行者占据最有利的竞争位置，将企业的技术优势转化 为市场优势。 作者：华鲁恒升办 ...

与参赛队深度交流精准筛选创新种子 在本次大赛中，雪龙集团并未局限于被动观察，而是组建了由技术、投资与业务部门骨干组成的专项对 接小组，主动深入路演现场，与参赛团队进行一对一深度交流。公司团队重点关注人工智能、大数据分 析与智能制造等领域的优质项目，从技术可行性、产业融合度及市场潜力等多维度进行专业评估。 12月18日，雪龙集团（603949）股份有限公司（以下简称：雪龙集团）以产业对接方身份，参与第二 届"AI宁波"人工智能赋能产业大赛暨第四届"硬核杯"创业创新大赛优质项目路演。公司代表团队全程参 与，与来自全国的优秀科创项目进行精准对接与务实交流，展现出雪龙集团以前瞻性产业视角聚焦前沿 科技、积极构建开放式创新生态的战略布局。 雪龙集团表示，未来，公司将继续扮演好产业方与创新者之间的"桥梁"角色，持续搜寻、培育并深度融 合具有战略价值的尖端科技，不断巩固自身在智能化、数字化时代的产业竞争力，为推动行业技术进步 与产业升级贡献雪龙力量。 此次大赛对接活动，清晰地传递出雪龙集团将科技创新置于集团发展核心战略的坚定决心。雪龙集团深 刻把握行业新能源化、智能化的长期发展趋势，积极进行新技术和新产品储备。坚持长期多元 ...

Core Insights - The Chinese foundry industry has maintained its position as the world's largest for 25 consecutive years, with a projected output of 50.75 million tons in 2024, accounting for approximately 45% of global production [1] - Despite leading in scale, the industry faces challenges such as a lack of high-end casting quality and heavy reliance on imported core materials, which hinders the upgrade to high-end manufacturing [1] - Yuzhou Hengli New Materials Co., Ltd. has emerged as a key player in the foundry sector, focusing on core additives like spheroidizing agents and core wires, contributing to the enhancement of China's foundry competitiveness [1] Group 1: Historical Context and Technological Development - The history of casting in China dates back to ancient times, with significant advancements in spheroidal graphite casting technology occurring in the mid-20th century [3] - The quality of spheroidal graphite castings is heavily influenced by the processes of spheroidization and inoculation, which are critical for achieving desired material properties [3] Group 2: Company Evolution and Market Position - Wang Yingzhan, the founder of Hengli, transitioned from a laboratory role to entrepreneurship, identifying market gaps in spheroidal graphite materials during China's economic reforms [4][6] - Hengli's spheroidizing agents gained recognition in the industry by 2006, establishing partnerships with leading companies like Nanyang Feilong, which produces a significant portion of China's automotive water pumps [8] Group 3: Innovations in Core Wire Technology - The development of core wire technology marked a significant leap for Hengli, allowing for more precise control of material addition and reduced emissions compared to traditional methods [9][11] - Initial challenges in production led to a commitment to quality, exemplified by the decision to discard defective products to maintain standards [13] Group 4: Industry Standards and Collaborations - Hengli has played a pivotal role in establishing industry standards for spheroidal graphite core wires, enhancing product reliability and market acceptance [16] - The company has collaborated with experts to address technical challenges, leading to innovations that have positioned Hengli at the forefront of the industry [23] Group 5: Advancements in Risers and High-Speed Rail Applications - Hengli's innovations in risers have addressed critical challenges in high-speed rail component manufacturing, ensuring defect-free production [19] - The establishment of industry standards for risers has further solidified Hengli's reputation as a leader in the foundry sector, contributing to the overall improvement of China's casting industry [21]

Core Insights - CEEDI has over 70 years of experience and plays a significant role in supporting the national electronic information industry and its major strategies [3][4] - The company focuses on providing integrated services throughout the entire lifecycle in the fields of electronic information and smart city construction [3][4] Company Overview - CEEDI offers a wide range of services including engineering design, investment consulting, planning consulting, special contracting, engineering procurement, construction, inspection and testing, and operation maintenance [3] - The company emphasizes talent as the "first resource" for high-quality development and implements a talent development strategy that includes both external recruitment and internal training [3] Talent and Workforce - CEEDI employs over 6,000 staff, including 9 national-level design masters, 46 experts enjoying government special allowances, and over 1,100 senior engineers and researchers [3][4] - The company has established a postdoctoral research station and an academician expert workstation to enhance its research capabilities [4] Technological Innovation - CEEDI adheres to the principle of "building platforms for innovation and gathering talent to strengthen the institute," focusing on open innovation [4] - The company has formed a three-tiered technology platform at the national, provincial, and institutional levels and has achieved significant technological results through five major technology strategies [4] Strategic Goals - CEEDI aims to serve the national innovation development strategy and the advanced electronic information industry, positioning itself as a leading provider of digital and intelligent solutions in the electronic information and smart city sectors [4]

Core Insights - The global beauty market is facing a "value return" challenge, with the Chinese market undergoing significant structural adjustments, moving from rapid growth to a more competitive landscape [1][2][6] - L'Oréal has demonstrated strong resilience and growth in this challenging environment, achieving "mid-single-digit growth" in the Chinese market, which is a notable performance amidst overall market stagnation [2][6][7] Financial Performance - L'Oréal's Q3 financial report shows a 3.7% year-on-year growth, with total sales reaching €32.8 billion, outperforming the sluggish market [5][6] - The online sales channel has seen double-digit growth, indicating L'Oréal's strong digital presence and market dominance [5] Market Strategy - L'Oréal's growth is driven by a robust recovery in the high-end cosmetics sector, capitalizing on the premium market segment [7] - The "Beauty Stimulus Plan" focuses on innovation and product line mobilization, enhancing the proportion of new products in the market [7][11] Innovation and R&D - L'Oréal is committed to long-term investment in China, marking the 20th anniversary of its R&D center, which has evolved from "in China" to "with China" and now "for China" [4][11] - The company showcased 26 new product launches at the recent expo, including three Asian debuts and four global launches, highlighting its innovation capabilities [11][12] Strategic Partnerships - L'Oréal has formed a strategic partnership with Kering, acquiring high-end fragrance brands and enhancing its position as a global leader in luxury beauty [10][15] - The "BIG BANG Beauty Tech Co-Creation Program" has successfully connected with numerous startups, fostering innovation in the beauty tech sector [13][21] Societal Impact and ESG - L'Oréal's commitment to ESG principles is evident, with a focus on creating jobs and driving economic growth, claiming to generate over 334,000 jobs in China [23][25] - The company has launched initiatives like the "New Age Beauty" concept, addressing societal issues related to aging and promoting a holistic view of beauty [24][25] Thought Leadership - L'Oréal aims to redefine beauty as a core economic driver, launching a book on the economics of beauty, which quantifies its impact on job creation and economic growth [20][23] - The company is positioning itself as a thought leader in the beauty industry, moving beyond product sales to influence industry standards and societal perceptions of beauty [17][18]

Core Insights - Jinqiu Fund participated in a strategic financing round for the AI for Science startup "Deep Principle," focusing on breakthrough technologies and innovative business models in the AI sector [3] - "Deep Principle" emerged as one of the top three winners in the "Foreseeing New Product Research" track at the 2025 BIG BANG Beauty Tech Co-Creation Program, which had over 700 participating startups [3] - The founder and CEO of "Deep Principle," Dr. Jia Haojun, highlighted the transformative impact of AI on material research during a roundtable forum, emphasizing the balance of depth, speed, and budget in beauty formulation development [6][8] Investment Highlights - Jinqiu Fund's long-term investment philosophy is centered on identifying promising AI startups with innovative approaches [3] - The AI-driven platform ReactiveAI developed by "Deep Principle" enhances research efficiency by predicting and explaining the effects of ingredients on formulation performance, leading to quantifiable benefits such as reduced R&D cycles and lower costs [6] Industry Trends - The 2025 BIG BANG event showcased the importance of open innovation in the beauty industry, as emphasized by L'Oréal's global R&D executive, who noted that collaboration is key to driving disruptive solutions [8][9] - The integration of AI in material research is seen as a significant shift from discovery to rational design, indicating a future where AI continuously improves through experimentation [6]

Core Viewpoint - Multinational pharmaceutical companies are reshaping their R&D models in China, focusing on open innovation to enhance efficiency and collaboration in drug development [1][3]. Group 1: Company Strategies - Eli Lilly has established its second innovation incubator in China, marking a significant step in its external innovation strategy [1]. - The company has three external innovation engines operational in China, including venture capital and innovation cooperation centers, indicating a comprehensive acceleration of its innovation strategy in the region [1]. - Other multinational companies, such as Roche, are also investing heavily in China, with Roche's accelerator involving over 10 early-stage R&D collaborations [1]. Group 2: Industry Trends - The average time for a new drug to move from the lab to patients is over 10 years, with oncology drugs costing around $2.3 billion to develop, highlighting the industry's long cycles and high costs [2]. - The success rate for oncology drugs from early development to approval is below 5%, emphasizing the challenges faced by pharmaceutical companies [2]. - The rise of local R&D capabilities in China is prompting multinational companies to engage more actively in early clinical research and collaborations with Chinese experts [3]. Group 3: Regional Development - The Zhangjiang area in Shanghai has become a leading hub for the biopharmaceutical industry, recognized for its complete industry chain, talent concentration, and innovative environment [4]. - Eli Lilly's strategic focus on China reflects the country's growing importance as a source of global innovation in the biopharmaceutical sector [4].

Core Insights - L'Oréal showcased its commitment to innovation and market expansion at the 8th China International Import Expo, emphasizing its theme "Beauty Without Limits" [1][3] - The company presented a strong lineup of 25 brands, including three Asian debuts and 19 new products, aiming to meet the growing beauty demands of Chinese consumers [3][4] - L'Oréal's CEO highlighted the importance of the Chinese market in the company's global strategy, marking it as the second-largest market and a key source of innovation [15] Product Launches - L'Oréal introduced several cutting-edge beauty technologies, including the global debut of the Paris Kérastase anti-hair loss treatment and the Lancôme Cell BioPrint skin analysis device [4][7] - The Nano Resurfacer 400 booster, a new home skincare device, was also launched, designed to enhance product efficacy through advanced nano-chip technology [7] Strategic Collaborations - L'Oréal announced three significant partnerships during the expo, including the establishment of a skin science laboratory in collaboration with Fudan University and Huashan Hospital [12] - The company initiated the "New Age Beauty China Action" in partnership with local organizations to promote research and discussions on aging and beauty [10][12] - A strategic memorandum of understanding was signed with Alibaba Cloud to explore advancements in cloud computing and artificial intelligence [14] Economic Impact - The launch of the book "The Path of Beauty" highlighted L'Oréal's economic contributions, stating that one job at L'Oréal creates 20 additional jobs in related fields, resulting in over 330,000 jobs created in China [8]

Core Insights - The establishment of the Harbour Mice-AstraZeneca Innovation Laboratory in Beijing marks a significant milestone in the collaboration between Harbour Mice and AstraZeneca, creating a diversified cooperation model that includes R&D collaboration, equity investment, and the establishment of an innovation center [1][3][5] Group 1: Collaboration and Innovation - The partnership aims to develop next-generation multi-specific antibody therapies targeting immune diseases, tumors, and other conditions, leveraging advanced technologies and resources [3][5] - The newly unveiled innovation laboratory integrates Harbour Mice's fully human antibody technology with AstraZeneca's expertise in disease biology, clinical development, and AI drug design, serving as a strategic hub for innovation [5][6] - The collaboration has evolved from a single licensing agreement to a comprehensive ecosystem-building approach, enhancing trust and cooperation between the two companies [7] Group 2: Technological Advancements - Harbour Mice's antibody technology platform, including the Harbour Mice and HCAb PLUS™ systems, addresses traditional challenges in antibody development, enabling the creation of fully human antibodies and expanding applications to bispecific antibodies, ADCs, CAR-T, RNA therapies, and AI [6][7] - The integration of AI and big data into the antibody development process is expected to significantly accelerate the research and development of new therapeutic antibodies [7][8] Group 3: Future Outlook - Harbour Mice plans to expand its pipeline from 5 to over 20 products, covering various therapeutic areas such as oncology, inflammation, metabolic diseases, and central nervous system disorders [8] - The company aims to strengthen its innovation capabilities and deepen platform empowerment, positioning itself as a key player in the global pharmaceutical innovation chain [8]

Core Viewpoint - Guangzhou is positioning itself as a significant international innovation center, leveraging its strong collaboration with the National University of Singapore to enhance technological innovation and talent development [1] Group 1: Government and Institutional Collaboration - The Mayor of Guangzhou, Sun Zhiyang, expressed gratitude to the National University of Singapore for its support in the city's economic and social development [1] - The collaboration is seen as a foundation for accelerating the construction of a modern industrial system referred to as "12218" [1] - The establishment of the Guangzhou Innovation Research Institute by the National University of Singapore has shown rapid development and significant results since its inception [1] Group 2: Innovation and Talent Development - Guangzhou aims to strengthen the transformation of scientific and technological achievements and enhance the cultivation of high-level talent [1] - The partnership is expected to deepen innovation cooperation between enterprises and universities in both regions, injecting new momentum into Guangzhou's modern industrial system [1] - The Mayor highlighted the importance of leveraging platforms like the Guangzhou National Laboratory and the Sino-Singapore Guangzhou Knowledge City for innovation [1]